Results 241 to 250 of about 188,184 (297)

Aseptic meningitis due to intravenous immunoglobulin therapy (IVIG) in therapy‐refractory pyoderma gangraenosum

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Katharina A. Kälber, Knut Schäkel, Alexander Enk, Julia K. Winkler   +3 more
wiley   +1 more source

Contemporary Management of Clot-In-Transit: Advances in Catheter-Directed Thrombectomy. [PDF]

JACC Case Rep
Kojodjojo P, Tay E.
europepmc   +1 more source

Massive aortic thrombus in a hypercoagulable patient with heparin induced thrombocytopenia: a case report. [PDF]

J Surg Case Rep
Messina JM, Pruekprasert N, Gilbert J, Sarabu M, Holmes C, Polomsky M.   +5 more
europepmc   +1 more source

Case Report: Postoperative pulmonary embolism causing obstructive shock and circulatory collapse after gynecologic surgery: successful rescue with VA-ECMO. [PDF]

Front Cardiovasc Med
Long NK, Dai HQ, Anh CHT, Dat PD, Tuan KM, Nhat TH, Tin NH, Tuan VPA, Nhut NM, Hai NT, Thuong DT.   +10 more
europepmc   +1 more source

The Next Frontiers in Stroke Prevention: Optimizing Left Atrial Appendage Closure in Atrial Fibrillation: Current Devices, Imaging-Guided Strategies, and Emerging Approaches. [PDF]

J Clin Med
Qassim ZAM, Patni MM, George BT, Kar SS, Dube R, Al Shaibani RMS, Yassin GH, Theyabat YM, Alabid I, Qassim MM.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

New anticoagulants

Current Opinion in Hematology, 2006
Abstract Traditional anticoagulant drugs, including unfractionated heparin and warfarin, have several limitations. New anticoagulants have been developed that target a single coagulation factor and have predictable dose-response relationships. These include direct thrombin inhibitors and factor Xa inhibitors.
AGNELLI, Giancarlo, BECATTINI, Cecilia
openaire   +6 more sources